Can Low Molecular Weight Heparins Circumvent the Problem of Coumadine and Chemotherapy Interaction in Cancer Patients with Prosthetic Heart Valves?

DOI QR Code

Sezer, Ahmet (Department of Medical Oncology, Baskent University School of Medicine) ;
Sumbul, Ahmet Taner (Mustaf Kemal University School of Medicine) ;
Abali, Gulcan (Acibadem University School of Medicine) ;
Sumbul, Zehra (Hatay State Hospital, Cardiology Clinic) ;
Muallaoglu, Sadik (Department of Medical Oncology, Baskent University School of Medicine) ;
Abali, Huseyin (Department of Medical Oncology, Baskent University School of Medicine)

Abali H, Ata A, Ozdogan M, Turhal S, et al (2011). Frequency of comorbid illnesses in cancer patients in Turkey. J BUON, 16, 557-60
Holbrook A, Schulman S, Witt DM, et al (2012). Evidencebased management of anticoagulant therapy: anti thrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest, 141, 152-84. https://doi.org/10.1378/chest.11-2295
Vahanian A, Alfieri O, Andreotti F, et al (2012). Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Guidelines on the management of valvular heart disease (version 2012). . Eur Heart J, 33, 2451-96. https://doi.org/10.1093/eurheartj/ehs109

Follow-up and management of valvular heart disease patients with prosthetic valve: a clinical practice guideline for Indian scenario vol.35, pp.S1, 2019, https://doi.org/10.1007/s12055-019-00789-z